Avadel Pharmaceuticals Correlations

AVDL Stock

USD 8.03 0.17 2.07%

A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Avadel Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Avadel Pharmaceuticals PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

Avadel Pharmaceuticals Correlation With Market

Modest diversification

The correlation between Avadel Pharmaceuticals PLC and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

Moving together with Avadel Stock

0.73	VINC	Vincerx Pharma Earnings Call Tomorrow	Pair Corr
0.76	ELVN	Enliven Therapeutics Downward Rally	Pair Corr
0.76	ZURA	Zura Bio Limited	Pair Corr
0.63	IMMX	Immix Biopharma	Pair Corr
0.73	INBX	Inhibrx Symbol Change	Pair Corr
0.76	MLTX	MoonLake Immunotherapeuti	Pair Corr
0.64	PMVP	Pmv Pharmaceuticals	Pair Corr
0.66	ATNF	180 Life Sciences	Pair Corr

Moving against Avadel Stock

0.63	PLX	Protalix Biotherapeutics	Pair Corr
0.6	SNY	Sanofi ADR	Pair Corr
0.53	AZN	AstraZeneca PLC ADR	Pair Corr
0.47	GILD	Gilead Sciences Potential Growth	Pair Corr
0.43	BMY	Bristol Myers Squibb	Pair Corr
0.41	LLY	Eli Lilly	Pair Corr
0.34	GOSS	Gossamer Bio	Pair Corr
0.69	CMPX	Compass Therapeutics	Pair Corr
0.59	AMGN	Amgen Inc	Pair Corr
0.58	RVP	Retractable Technologies Earnings Call Tomorrow	Pair Corr
0.57	DRMAW	Dermata Therapeutics	Pair Corr
0.39	NVCT	Nuvectis Pharma	Pair Corr

Related Correlations Analysis

	NBIX	DCPH	IRWD	ALKS	ITCI	DVAX	DERM	EVOK	JUPW	AQST
NBIX		0.0	0.72	-0.77	-0.38	-0.71	-0.77	0.4	0.0	0.44	NBIX
DCPH	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	DCPH
IRWD	0.72	0.0		-0.87	-0.79	-0.73	-0.79	0.35	0.0	0.7	IRWD
ALKS	-0.77	0.0	-0.87		0.69	0.7	0.75	-0.21	0.0	-0.56	ALKS
ITCI	-0.38	0.0	-0.79	0.69		0.43	0.38	-0.31	0.0	-0.75	ITCI
DVAX	-0.71	0.0	-0.73	0.7	0.43		0.71	-0.56	0.0	-0.62	DVAX
DERM	-0.77	0.0	-0.79	0.75	0.38	0.71		-0.32	0.0	-0.35	DERM
EVOK	0.4	0.0	0.35	-0.21	-0.31	-0.56	-0.32		0.0	0.35	EVOK
JUPW	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	JUPW
AQST	0.44	0.0	0.7	-0.56	-0.75	-0.62	-0.35	0.35	0.0		AQST
	NBIX	DCPH	IRWD	ALKS	ITCI	DVAX	DERM	EVOK	JUPW	AQST

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DERM	+ 0.75	ALKS
IRWD	+ 0.72	NBIX
DERM	+ 0.71	DVAX
AQST	+ 0.7	IRWD
DVAX	+ 0.7	ALKS
ITCI	+ 0.69	ALKS

High negative correlations

ALKS	- 0.87	IRWD
DERM	- 0.79	IRWD
ITCI	- 0.79	IRWD
DERM	- 0.77	NBIX
ALKS	- 0.77	NBIX
AQST	- 0.75	ITCI

Risk-Adjusted Indicators

There is a big difference between Avadel Stock performing well and Avadel Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Avadel Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NBIX	1.47	(0.22)	0.00	(0.23)	0.00	0.00	1.83	(3.11)	20.72
DCPH	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
IRWD	4.11	(1.05)	0.00	(0.46)	0.00	0.00	5.67	(10.26)	52.86
ALKS	1.36	0.15	0.11	0.31	1.31	(1.65)	3.78	(2.48)	10.24
ITCI	1.56	0.71	0.82	(23.55)	0.00	(1.78)	1.77	(1.34)	34.42
DVAX	1.06	0.12	0.08	0.65	1.36	(1.13)	2.36	(1.97)	7.23
DERM	3.27	0.52	0.15	1.48	3.19	(3.89)	8.05	(4.80)	24.62
EVOK	3.49	(0.59)	0.00	(0.38)	0.00	0.00	6.88	(8.02)	47.09
JUPW	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
AQST	3.30	(0.19)	0.00	(0.11)	0.00	0.00	6.23	(7.48)	21.67

Avadel Pharmaceuticals Corporate Management

Gregory Davis	VP Development	Profile
Richard Kim	Chief Officer	Profile
Christian PharmD	Chief Affairs	Profile
Steven Sullivan	VP Operations	Profile
Jason Vaughn	Senior Operations	Profile
Jennifer PharmD	Senior Affairs	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC